DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Menu 返回 Medical-Devices-and-Combination-Products

Medical Devices & Combination Products

Healthcare systems worldwide face a range of challenges - from rising rates of chronic diseases and aging populations to a lack of healthcare professionals. These challenges can be addressed in part through innovative therapies and concepts that improve patient empowerment and autonomy. To achieve this, the worlds of medical devices and pharmaceuticals must move closer, creating a regulatory environment supportive of rapid digital innovation and the merging of technologies – starting with better devices for medicines’ application and extending to new smart applications to assist patients, caregivers, and healthcare professionals. Digital innovation has the potential to revolutionize the healthcare industry, from AI-powered medical devices that can diagnose diseases more accurately to telemedicine platforms that enable remote consultations and monitoring. By embracing digital innovation, we can improve patient outcomes, increase efficiency, and reduce costs in the healthcare system.

Who is This Track Designed For?

We welcome interest and involvement from a broad spectrum of individuals and organisations – including but not limited to - authorities, Notified Bodies, patient organisations, and manufacturers of devices and combination products.

Topic Leader

Sabina Hoekstra-van den Bosch

Sabina Hoekstra-van den Bosch

Regulatory Strategy Principal

TÜV SÜD, Netherlands

Thomas Mller

Thomas Wejs Moller

Director Global Regulatory Affairs - Devices

Novo Nordisk, Denmark

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。